Skip to main content
. 2023 Jun 7;37(18):3725–3733. doi: 10.1038/s41433-023-02610-z

Fig. 1. Schematic representation of tyrosine kinase inhibitors (TKIs) and the receptors they target.

Fig. 1

Ang 2- Angiopoietin 2; Flt- fms like tyrosine kinase; KDR-Kinase insert domain receptor;PDGF-Platelet derived growth factor; PDGFR- Platelet derived growth factor receptor; PIGF- Placenta growth factor;VEGF- Vascular endothelial growth factor; VEGFR- Vascular endothelial growth factor receptor.